Publicerad: 2022-06-09 10:31 | Uppdaterad: 2022-06-09 10:37

Aktuella utlysningar, vecka 23, 2022

Grants Office tipsar om aktuella utlysningar.

Svenska och nordiska utlysningar

KI internal call: SRP Diabetes Student Degree Project Grants

For the fall term of 2022. This aims to support principal investigators at Karolinska Institutet (KI) planning to supervise a student in an educational program at KI (e.g. medical students, biomedicine programme, master programmes) while the student performs his/her degree project work during the fall term of 2022. Projects should be in the area of diabetes and/or metabolism.

Support/grant: 25 000 SEK (incl INDI) for a 10-week project, 40 000 SEK (incl INDI) for a 20-week project

Closing date: 1 July 2022

Further information

Projektanslag - Stiftelsen Stig Thunes fond för omvårdnadsforskning inom området reumatiska sjukdomar

Stiftelsen välkomnar sökande från alla professioner inom området omvårdnad och rehabilitering vid reumatisk sjukdom. Forskningsprojektet ska ha vetenskaplig status och ansökan ska vara komplett och av god kvalitet. Sökande får endast vara huvudsökande i ett projekt. Det utgör inget hinder att vara medsökande i två andra projekt. Forskningsanslag beviljas maximalt 3 gånger för samma projekt.

Closing date: 1 October 2022

Further information

Swedish Society of Nursing

  • Project grant: support nurses who conduct development and research work, want to start clinical development projects or who are at the beginning of their doctoral education. The total budget is SEK 80,000.
  • Ebba Danelius foundation: supports research and development projects by nurses related to children and young people’s health.
  • Ulrica Croné´s foundation: aim to improve the care of seriously ill and dying patients. The total budget is SEK 50,000

Closing date: 7 October 2022

Further information

Europeiska utlysningar

José Baselga fellowship for clinician scientists - European Society for Medical Oncology

The European Society for Medical Oncology invites applications for the José Baselga fellowship for clinician scientists. This supports physicians in the field of oncology who are developing their careers as clinician-scientists by providing protected time for research. The fellow will be paired with a mentor who is a member of the ESMO faculty corresponding to their field of research.

Applicants must be qualified medical or clinical oncologists with at least one year of experience in medical, radiation or surgical oncology and be currently engaged in cancer research or clinical oncology practice. They must be an ESMO member and be under the age of 40 when applying. The fellowship must take place at a European institution and fellows are expected to spend at least 50 per cent of their time on a research project. Funding is worth €200,000 to supplement the salary of one fellow over a period of three years.

Closing Date: 19 June 2022

Further information

Advanced research grants in amyotrophic lateral sclerosis - Radala Foundation for ALS Research

The Radala Foundation invites applications for its advanced research grants in amyotrophic lateral sclerosis (ALS). These support potentially ground-breaking, high-risk projects in basic research in ALS. Grants are for studies of the understanding of the basic causes of the disease, and clinically related projects for patient care are not eligible.

Established, leading PIs may apply. They are expected to be active researchers and have a track-record of significant research achievements in the last 10 years. Research must be conducted in a public or private research organisation. There are no geographical limitations. Up to two grants are available, each worth CHF 200,000 over two years

Closing Date: 30 June 2022

Further information

Marie Skłodowska-Curie Actions (MSCA) Postdoctoral Fellowships 2022

The MSCA 2022 Postdoctoral Fellowships is open with closing date on September 14th 2022. With the MSCA Postdoc Fellowships you can do a postdoc either within Europe with a 2-year fellowship (European Fellowship), or outside Europe (2 years) with a mandatory 1-year return phase to Europe with the 3-year Global Fellowship.

KI information 

Info about the program

How to apply

Link to the call

Bootcamp MSCA Postdoc Fellowships for proposal writing are offered to those who apply with KI as Host Organization. Invited speakers are Vladimir Pabon-Martinez, KI Career Service for Courses and Career events, Nikolaos Volakakis, KI Compliance and Data Office for Data Management Plan, Tamsin Lindström, KI Grants Office for Sex and Gender aspects as well as MSCA fellows.

Dates for the Bootcamp:

  • Wed 15 June – whole day (10:00-16:30). Setting up the proposal according to award criteria. 
  • Mon 15 August, 13-16. Structure, EXCELLENCE.
  • Thur 18 August, 13-16 IMPACT.
  • Tue 23 August, 13-16 IMPLEMENTATION.
  • Thur 25 August, 13-16. Discussion with MSCA fellows.
  • Tue 30 August, 13-16  CV, Ethics, Tips on writing.

Bootcamp registration and info

For questions contact

Marie Skłodowska-Curie Actions (MSCA) Doctoral Networks 2022 (former ITN)

In the MSCA 2022 Doctoral Networks, Principal Investigators participate or coordinate a Consortium that applies for a training program for PhD students. The PhD students are to be recruited after the project is awarded. The MSCA Doctoral Networks program includes training networks, Industrial Doctorates and Joint Doctorates.

Closing Date: 15 November 2022

KI information 

Info about the MSCA DN program 

How to apply

Link to the call

MSCA Doctoral Networks application - For KI researchers who apply as Coordinators of the consortium, Grants Office offers

  • a workshop on DN-proposal writing with an external consultant  
  • Peer review

If there are enough interest from PIs at KI applying as Coordinator, Grants Office will set up the workshop and peer-review. Email and state if you are interested in a workshop in DN-proposal writing or Peer Review, or both.

Excellence award - Federation of European Biochemical Societies

The Federation of European Biochemical Societies invites applications for its excellence award. This provides early-career group leaders with the means to purchase laboratory equipment and consumables.

Candidates must have obtained their PhD up to six years prior to the submission of their proposals and have worked in a different country for at least two years prior to their current employment. They must hold a salaried in a host institution of of a FEBS country during the three years of the duration of the award and have established and operated at the host institution for at least one year. Applicants must have a current membership of a FEBS constituent society. The award is worth €100,000.

Closing Date: 01 July 2022

Further information

Research and networking grant - European Society for Paediatric Gastroenterology, Hepatology and Nutrition

The European Society for Paediatric Gastroenterology, Hepatology and Nutrition invites proposals for its research and networking grant. These enable members to undertake research activities and network among centres at an international level. Activities may include interactive educational events and clinical networks. Proposals relevant to the society’s activities, such as the validation of guidelines, or clinical networks for testing treatment regimes or disease management, are encouraged.

Main applicants must be members of the society and all projects must include more than one country. Non-society members may participate in collaboration with society members. Collaboration between two or more society members in different centres is required. The grant is worth up to €50,000.

Closing Date: 31 July 2022

Further information

HORIZON-EIC-2022-WomenInnovatorsPrize – EU prize for women innovators - Horizon Europe

The European Innovation Council, under Horizon Europe: Innovative Europe, invites applications for the EU prize for women innovators. This recognises women entrepreneurs who have founded a successful company and bought innovation to the market.

Applications are welcomed from all innovative companies, whatever their area of activity. Applicants must be established in an EU member state, including overseas countries and territories, or a country associated to Horizon Europe. They must be a founder or co-founder of an active innovative company registered at least two years before the submission deadline.

Three €100,000 prizes are awarded in the main category and three €50,000 prizes are awarded to promising rising innovators aged 35 or younger.

Closing date: 18 August 2022

Further information

Upcoming ERC Synergy call

The tentative deadline for applications to the next ERC Synergy Grant call (officially ERC-2023-SyG) is 8th November 2022. The dates and details may change and cannot be confirmed until the corresponding annual ERC Work Programme and guide for applicants is released (mid-summer 2022), but the ERC does not anticipate any major changes in this funding scheme. These are very competitive grants, and preparations for applying should be made well in advance. Please contact Tamsin Lindström at KI Grants Office if you are interested in applying for an ERC Synergy Grant.

What proposals are eligible?

Applications can be made in any field of research but must demonstrate that the proposed research cannot be carried out by a single PI working alone. Synergy projects should enable substantial advances at the frontiers of knowledge, stemming, for example, from the cross-fertilisation of scientific fields, from new productive lines of enquiry, or new methods and techniques, including unconventional approaches and investigations at the interface between established disciplines. Proposals will be evaluated on the sole criterion of scientific excellence, including outstanding synergy. These are very competitive grants. Please consult the ERC Synergy project summaries.

Who can apply?

ERC Synergy Grants fund small groups of two to four PIs working in an integrated fashion to bring together different skills and resources to tackle ambitious research problems. PIs must present an early achievement track-record or a ten-year track-record, whichever is most appropriate (please consult the lists of ERC Synergy grantees). One PI per 'Synergy Grant group' at any one time can be hosted or engaged by an institution outside of the EU or Associated Countries. 

How much?

Synergy Grants can be up to a maximum of € 10 million for a period of 6 years. An additional € 4 million can be requested under certain circumstances.

Follow this link to register for the national ERC Synergy webinar webinar on June 15th.

Frontiers of knowledge awards-- BBVA Foundation, ES

The BBVA Foundation invites nominations for its frontiers of knowledge awards. These recognise contributions in a broad array of areas of scientific knowledge, technology, humanities, and artistic creation. Awards are available in eight categories, including ‘biology and biomedicine’.

Nominees may be one or more natural persons of any nationality. Organisations may nominate more than one candidate, but each candidate may only be nominated for one category.

Awards are worth €400,000 each. In the event of an award being shared by more than one person, its monetary amount will be divided equally among all recipients.

Closing date: 30 June 2022

Further information

Roger De Spoelberch prize -- Roger De Spoelberch Foundation | Fondation Roger De Spoelberch, CH

This recognises a clinical and basic scientific research project within the field of neurodegenerative diseases and psychiatric disorders.

Applicants must hold a PhD and be under the age of 55 when the application is submitted. 

The prize is worth up to €750,000, at least two-thirds of which must be spent directly on research and development costs. Funding may be used to cover the staff, investment, and operating costs. 

Closing date: 30 June 2022

Further information

Primary bone cancer consortium funding support -- Bone Cancer Research Trust, GB

This supports high-impact collaborative research to improve outcomes for patients with primary bone cancer. The trust will support all stages or research, from pilot projects through to more substantive research and the essential infrastructure that underpins this research. Research should include patient and public involvement.

UK and international academic institutions may apply. However, applicants from outside the UK will need a UK-based co-applicant and collaborators. Consortia must include at least five participating countries.

Funding is worth up to £240,000 for at least three years.

Closing date: 1 July 2022

Further information

Quest for cures – collaborative discovery teams -- Brain Tumour Charity, GB

These support projects with innovative approaches to address the critical questions that could present a paradigm shift for brain tumour research or use unexplored paths to allow for new discoveries to be made. The scheme aims to fund preclinical studies that:

•foster a collaborative research process;

•strengthen the ties between basic and clinical research;

•promote transformational brain tumour research advances with the potential for rapid clinical translation.

Applicant teams must include both established and promising researchers from multidisciplinary backgrounds and they should be formed of researchers across at least two or three institutions. The collaborative team must have the relevant expertise of laboratory and clinical researchers to demonstrate how discoveries will be translated and taken forward to patient benefit. The call is open to international researchers, but applications including a UK collaborator will be looked on favourably. 

Closing date: 12 July 2022

Further information

Research grants -- Tom Wahlig Foundation, DE

These support research into, or with conceptual connections to, the hereditary spastic paraplegias. Topics to be covered may be clinical, genetic or functional in nature, and projects may represent self-contained small studies or be intended to generate preliminary data that enable alternative subsequent funding for a larger follow-up study.

Junior scientists within five years of their thesis for PhDs, or eight years of their thesis for MDs, are especially encouraged to apply.

Two to three grants, worth between €25,000 and €35,000 each, are available.

Closing date: 15 July 2022

Further information

Share4Rare open call for patient-driven research projects, ES

Share4Rare invites applications for its call for patient-driven research projects. This enables patient organisations and researchers in the field of rare diseases to conduct their patient-centred studies using the Share4Rare digital platform, designed to enhance patient and carer knowledge. The platform allows users to communicate with patients, their carers and their families, in order to collect their perspective on rare diseases.

Patient organisations and academic institutions, as well as other related stakeholders interested in

promoting patient-centered research in rare diseases, may apply.

Funding is worth up to €15,000 to cover staff costs and support services, which must be matched by the applicant.

Closing date: 15 July 2022 (Forecast)

Further information

PPPA-2021-AIPC call for developing artificial intelligence for diagnosis and treatment of paediatric cancer, EU

The Directorate-General for Communications Networks, Content and Technology invites proposals for its PPPA-2021-AIPC call for developing artificial intelligence for diagnosis and treatment of paediatric cancer. This supports the development of multi-national approaches to facilitate capturing data on paediatric cancer from multiple sources and to build a multi-stakeholder network to explore the applications of artificial intelligence technologies in paediatric cancer. The project should focus on multiple applications, for example radiological imaging, digital pathology, digital twins, integrated genotyping and outcome prediction algorithms and clinical decision-making. Eligible activities include conferences and seminars, awareness and dissemination actions, creation and improvement of networks, studies, analyses and mapping projects, and research activities.

Non-profit private or public organisations, for-profit private organisations with relevant expertise, universities and research centres established in EU member states or EEA countries, may apply. Consortia must consist of at least five legal entities from at least three different countries.

One grant is available, worth up to €1.3 million over a maximum period of one year. Funding may cover up to 75 per cent of eligible costs.

Ref: PPPA-2021-AIPC.

Closing date: 20 July 2022 (Forecast)

Further information

ECCO grants and fellowships -- European Crohn's and Colitis Organisation, EUR

Ecco Pioneer Award

This aims to encourage and support innovative basic or clinical scientific research in inflammatory bowel diseases across Europe. Projects must be new, original, and not yet be launched.

A multi-centre project group or a single centre may apply. All applicants must be members of the organisation.

One award worth €300,000 for a duration of two years is available.

Ecco Grants

These support innovative scientific research in inflammatory bowel diseases in Europe.

Young basic or clinical scientists up to the age of 40, or above if within five years of finishing gastrointestinal training or PhD graduation. They must be members of the society. Research is usually undertaken at the applicant’s home institution.

A total of eight awards, worth €80,000 each, are available for one year.

Ecco Fellowships

These encourage young individuals in their career and to promote innovative scientific research in inflammatory bowel diseases in Europe.

Applicants must not be older than 40 years or still in training at the time of application. They must have a hosting institute outside their own country which has accepted to host and supervise them, and both the applicant and their hosts must be ECCO members. Applications are not restricted to individuals from ECCO member countries and applicants may be from non-European countries.

A total of two awards worth €60,000 each, over one year are available.

Closing date: 01 August 2022

Further information

Action grant to support a HERA laboratory network - European Health and Digital Executive Agency

The European Health and Digital Executive Agency invites applications for is action grant to support a HERA laboratory network. This grant aims to establish a pilot network of top-class laboratories and research institutes that have the critical expertise and capacities to provide the information needed in the shortest possible timeframe and to support HERA in identifying emergent pathogens and ensuring the availability of medical countermeasures for improved health preparedness and response.

Applicants must come from EU member states, Iceland, Norway, Liechtenstein and Bosnia and Herzegovina.

The budget is €25 million for one grant.

The costs will be reimbursed at the funding rate fixed in the Grant Agreement (60%). You can apply for a higher project funding rate (80%) if your project is of ‘exceptional utility’.

Indirect cost flat-rate: 7% of the eligible direct costs

Closing date: 18 Aug 2022

Further information

Call for proposals for the European Foodome project - European Food Safety Authority

 The European Food Safety Authority invites proposals for its call on the European Foodome project. This supports the creation of a well-structured, comprehensive food composition database by taking advantage of AI technologies. The aim is to reduce knowledge gaps of incomplete biochemical composition of food that limits regulators and health professional's ability to systematically explore how diets impact our health. In addition, the project should also explore how to systematically unveil the mechanistic role of some molecules found in our diets, by building on the findings from recently published pioneering work in linking food chemicals to diseases.

Closing date: 29 August 2022

Further information

3R science prize - European Partnership for Alternative Approaches to Animal Testing

 The European Partnership for Alternative Approaches to Animal Testing invites applications for its 3R science prize. This aims to promote the development, validation and acceptance of the three Rs alternative approaches of replacement, reduction and refinement of testing on animals.

Applicants should be based in Europe and have no more than 10 years of postgraduate experience. The prize is awarded for a research project completed within the last five years.

Closing date: 3 October 2022

Further information

Horizon Europe application support - United European Gastroenterology

The United European Gastroenterology invites applications for its Horizon Europe application support. This offers assistance in the EU research funding application process related to digestive health.

Individuals engaged with Pan-European consortium forming initiatives in the exploratory phase of applications to Horizon Europe may apply.

The funder invests up to €10,000 per consortium, providing meeting facilities, catering and other logistical meeting support onsite, reimbursement of costs for accommodation and travel, and advice from large community of experts in digestive health.

Closing date: Applications are considered and accepted on a rolling basis.

Further information

Starting grants - Frick Foundation for ALS Research

 The Frick Foundation for ALS Research invites applications for its starting grants. These support basic biomedical research related to amyotrophic lateral sclerosis.

Applicants may be researchers of any nationality with five years of postdoctoral experience and potential to be a research leader. Research must be conducted in a public or private research organisation.

Two grants are available, each worth CHF 100,000 over two years.

Closing date: 30 September 2022

Further information

Biopharma speed grant Merck, DE

Merck invites applications for its biopharma speed grant. This provides fast funding to pre-clinical researchers in the fields of oncology, immuno-oncology, autoimmune disorders and drug discovery technologies.

Healthcare professionals and healthcare organisation employees are ineligible.

Grants are worth up to €30,000 each.

Further information

Ukrainian short-term fellowships - Federation of European Biochemical Societies, EUR

The Federation of European Biochemical Societies invites applications for its Ukrainian short-term fellowships. These enable active molecular life scientists who are resident in Ukraine, or who have been displaced from Ukraine as a result of war in the country, to visit a host laboratory for a period of up to four months. The aim is to help Ukrainian molecular life scientists to develop scientific collaborations with host researchers and organisations in FEBS countries, with the hope of attracting further funding to extend their joint research stay if required. The collaborations should be of mutual research interest to both fellow and host and could involve developing joint research projects, undertaking advanced training or employing techniques not available at the usual place of work.

Applicants must have a PhD and at least one recent paper published within the last three years in an international scientific journal.

Fellowships include a stipend of €12,000 and a daily subsistence allowance of €100 per day.

Closing date: No deadline

Deadline Information: You can apply for this opportunity at any time.

Further information

Core facility fellowships - European Molecular Biology Organisation, EUR

The European Molecular Biology Organisation invites applications for its core facility fellowships. This supports training for staff of core facilities in carrying out international exchanges.

Applicants must be active researchers or technicians working in a core research facility with at least one year of laboratory experience. Training exchanges must take place between institutions in member states, associate member state or cooperation partners. Exceptionally, applications involving institutions in Japan may be considered.

Fellowships are intended for visits between week up to one month. Funding covers travel and subsistence.

Closing date: No deadline

Deadline Information: You can apply for this opportunity at any time.

Further information

Call for proposals for using the Interactive Computing E-Infrastructure - Human Brain Project, EU

The Human Brain project invites proposals for using the Interactive Computing E-Infrastructure. This enables European neuroscientists to use the Interactive Computing E-Infrastructure for their research.

Applicants may be researchers of the core Human Brain Project or its partnering projects, service providers for the EBRAINS research platform, or other researchers and groups contributing to research in this field, in particular those focusing on:

•analysis of brain data leading to understanding brain function;

•building multi-scale scaffold theory and models for the brain;

•simulation of brain function;

•brain-inspired computing, data analytics and robotics.

A total of 25 per cent of available ICEI resources are being made available through the HBP. Applicants should target allocation of resources that do not exceed 12 months, but proposals may be renewed.

Closing date: No deadline

Deadline Information: You can apply for this opportunity at any time.

Further information

Amerikanska utlysningar

Federal Funding agencies

Research grant, DoD Funding Opportunities for Parkinson’s Research Program (PRP): Department of Defense

The PRP supports highly rigorous, multidisciplinary, high-impact research projects that have the potential to make an important contribution to Parkinson’s research. All applications must address at least one of the following FY22 PRP Focus Areas:

  • Biological mechanisms or biomarkers of non-motor symptoms that could lead to the development of treatments for PD. Examples of non-motor symptoms of interest include:
    • Cognitive dysfunction relevant to PD
    • Psychiatric dysfunction
    • Sleep and circadian rhythms disruptions
    • Autonomic dysfunction
    • Sensory dysfunction
    • Fatigue
  • Biological mechanisms or biomarkers associated with non-pharmacological interventions for non-motor symptoms of PD. Examples of non-pharmacological interventions of interest include:
    • Exercise
    • Diet
    • Neuro-stimulation therapy
    • Neurosurgical

Closing date: Early Investigator Research Award; Investigator-Initiated Research Award; Synergistic Idea Award – LOI due 16th August, 2022 (5:00pm, ET); Full proposal due 1st September, 2022 (11:59pm, ET)

Further information

Research grant, DoD Funding Opportunities for Melanoma Research Program (MRP): Department of Defense

The clinical, research, and patient communities traditionally view prevention as the use of sunscreen/blockers to protect melanocytes from harmful ultraviolet (UV) radiation. The MRP tasks the research community to redefine prevention to include the entire melanomagenesis process for all variants of melanoma. A new paradigm of prevention includes improved detection and monitoring capabilities, as well as inhibiting the initiation of melanoma, the emergence from tumor dormancy, and the development of metastases. To be considered for funding, applications must address at least one of the following FY22 MRP Focus Areas:

  • Research across the entire spectrum (biology, etiology, prevention, diagnosis and detection, prognosis, treatment, and quality of life) for rare melanomas (e.g., uveal, acral, mucosal, pediatric) in patients and model organisms.
  • Identify and understand risk factor determinants for melanoma, including rare subtypes.
  • Develop prediction and surveillance tools for distinguishing patient populations at risk for second primary/recurrence and/or metastasis.
  • Understand how precursor lesions and environmental/endogenous factors influence melanomagenesis, including (but not limited to) race, sex as a biological variable, etc.
  • Develop new tools for the detection and diagnosis of melanoma, which includes easily accessible technology (beyond the dermoscope) for primary care physicians and dermatologists.
  • Identify how the tumor microenvironment (e.g., stromal, immune, microbiome) impacts tumor initiation, response to therapy, progression, recurrence, and/or dormancy.
  • Delineate the molecular pathways that influence metastatic spread, recurrence, and/or dormancy.

Closing date: Focused Program Award; Academy Scholar Award; Mid-Career Accelerator Award; Team Science Award - LOI due 14th September, 2022 (5:00pm, ET); Full proposal due 5th October, 2022 (11:59pm, ET). Idea Award  - LOI due 8th July, 2022 (5:00pm, ET); Full proposal due 5th October, 2022 (11:59pm, ET).

Further information 

Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed): NIH

NIDA seeks to stimulate innovative research that will transform our understanding of the basic mechanisms that underlie polysubstance use in addiction. These studies will investigate novel neurobiological, pharmacological and/or behavioral mechanisms that drive the behavioral and pharmacological profiles observed following polysubstance use. The major goal of the project must be targeted at delineating basic mechanisms underlying polysubstance use in addiction. Projects must focus on combinations of two or more addictive substances with well-justified translational and public health relevance. Research areas and questions of programmatic interest include, but are not limited to:

  • Identification and/or characterization of molecules, genes, cells (including non-neuronal cells), neural pathways, circuits, receptors, ion channels, intrinsic excitability, pharmacological and signaling mechanisms mediating the effects of polysubstance use.
  • Mechanisms underlying the association of early adolescent polysubstance use with SUD’s in adulthood.
  • Are there sex differences in the development and trajectory of polysubstance use?
  • What are the developmental determinants? Are there developmental windows during which polysubstance use would be facilitated?
  • How do environmental factors interact with brain circuitries to influence the development and trajectory of SUDs involving polysubstance use?
  • How does stress interact with brain circuitries to influence the development and trajectory of SUDs involving polysubstance use?
  • Are there neurobehavioral risk phenotypes for progression to polysubstance use?
  • Preliminary data are not required but may be included if available.

Closing date: November 14, 2022. Applications are due by 5:00 PM local time of applicant organization.

Funding Opportunity Announcement (FOA): RFA-DA-23-015 (RO1)

Further information


Research grant, Endeavor Award, The Mark Foundation for Cancer Research, US

The Mark Foundation Endeavor Awards support collaborative research projects that bring together investigators with diverse areas of expertise to tackle challenges in the prevention, diagnosis, and treatment of cancer. These grants are awarded to teams of three or more investigators to generate and integrate data from diverse lines of research and transform those insights into advances for cancer patients that could not be achieved by individual efforts. Projects should:

  • Be basic, translational, and clinical projects.
  • Seek to address an overarching, urgent scientific question.
  • Sub-projects should be designed to elucidate various aspects of the overarching question, theme, or focus.
  • The output of the individual team members (data, samples, hypotheses, compounds, etc.) must be integrated and/or shared in a way that makes the impact of the project as a whole larger than the sum of its parts.

Eligibility: Applicants must have an independent faculty research appointment (tenure-track or equivalent) at a non-profit academic institution. Investigators may be co-PI or collaborator on more than one proposal but may only serve as Principal Investigator on one proposal.

Budget: Endeavor Awards are $3,000,000 disbursed over a 3-year term. The budget limit includes both direct and indirect costs, with indirect costs not to exceed 10% of the direct costs. Proposed projects must not be supported by other sources of funding.

Closing date: LOI – July 13th, 2022. Finalist team interviews – October/November 2022. Full application – December 2022.

Further information

Research grant, Brian D Novis grants, International Myeloma Foundation, US

The International Myeloma Foundation funds several research grants including the Brian D. Novis Research Award. These awards go to researchers doing work in the field of multiple myeloma and related disorders including smoldering myeloma, MGUS (monoclonal gammopathy of undetermined significance) as well as immunoglobulin derived amyloidosis. Two grant types will be available during this funding call:

Junior grants: starter grants for early-career researchers. Budget: $50,000. Indirect costs a maximum of 10% of total award. Eligibility: Completed postdoctoral studies or clinical fellowships no later than October 1 of the application year. Ability to devote a minimum of 50% of his or her time to the research project during the Award year. Previous experience with NIH, other foundations or similar funding agencies.

Senior grants: these awards are targeted to established investigators with a track record in myeloma or related disorders, and are designed for projects which represent a different focus, direction, or area of research from those in which they are currently funded.  In most cases, these awards will be for pilot projects to obtain sufficient funding for larger applications from NIH or similar larger funding agencies. Budget: $80,000. Indirect costs a maximum of 10% of total award. Eligibility: Previous experience with NIH, other foundations or similar funding agencies.

Closing date (both grants): 1st September, 2022.

Further information

Research grant, Medical Toxicology Foundation/SAEMF Toxicology Research Grant, Society for Academic Emergency Medicine Foundation

The mission of the grant is to provide support for research proposals that advance the science of medical toxicology in emergency medicine. The goals are to foster collaboration between members of ACMT and SAEM and to advance the science of medical toxicology as it relates to all aspects of emergency medicine. Proposals that intend to collect data necessary to pursue larger projects (pilot projects) are of particular interest. The research proposals can address one or more of the following areas and topics:

  • Medical toxicology practice.
  • Medical toxicology education (medical students, emergency medicine residents, medical toxicology residents and emergency physicians).
  • Acute or chronic toxicity from pharmaceuticals and chemicals.
  • Envenomations and natural toxins.
  • Opioid-use disorders and addiction medicine.
  • Chemical or radiological emergency preparedness.
  • Global medical toxicology.

Eligibility: The applicant must: be a member in good standing of SAEM at application deadline and during the entire award period; be a physician holding an applicable terminal clinical degree (e.g., MD, DO); be an emergency medicine resident, or a medical toxicology fellow, or faculty member in good standing in an Accreditation Council on Graduate Medical Education (ACGME)-approved emergency medicine residency program are also eligible for the award; not have received the MTF-SAEMF Toxicology Research Grant previously.

Budget: The MTF-SAEM Foundation Toxicology Research Grant will provide up to $20,000 for an applicant’s project, contingent on the availability of funds. Funds from the grant may be used for direct costs related to the project. A maximum of $1000 may be used for travel to conferences to present research findings.

Closing date: Full application – 1st August 2022, 5pm Central time.

Further information